LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2α

This publication has 25 references indexed in Scilit:

• 6-oxo-PGF1 αand 8-epi-PGF2 αin the arterial wall layers of various species: a comparison between intact and atherosclerotic areas
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2001
• 6-oxo-PGF1αand 8-epi-PGF2αin human atherosclerotic vascular tissue
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1999
• Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
  Journal of Clinical Investigation, 1997
• THE INFLUENCE OF ISOPROSTANES ON ADP-INDUCED PLATELET AGGREGATION AND CYCLIC AMP-GENERATION IN HUMAN PLATELETS
  Thrombosis Research, 1997
• Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
  Circulation, 1997
• Coronary artery constriction by the isoprostane 8‐epi prostaglandin F_2α
  British Journal of Pharmacology, 1996
• Effects of the isoprostane, 8-epi-prostaglandin F2α, on the contractility of the human myometrium in vitro
  European Journal of Pharmacology, 1995
• Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-Isoprostane
  Biochemical and Biophysical Research Communications, 1993
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
  Proceedings of the National Academy of Sciences, 1990